Literature DB >> 11766268

[Probiotics--possibilities and limitations of their application in food, animal feed, and in pharmaceutical preparations for men and animals].

G Reuter1.   

Abstract

Probiotics are cultures of special microorganisms, which have been used as feed additives since the seventies of the past century and already since the twenties in food specimen and in pharmaceuticals. The definition of "Probioticum" was formulated in 1974 simultaneously with the use of living cultures in feed for various animals in order to substitute the application of nutritive antibiotics or chemotherapeutics. In the meantime probiotics are applied not only as feed supplements or pharmaceuticals but increasingly in suitable food specimens such as dairy products, fruit juices, chocolates, and even meat products. Of course, heating of such products prior to consumption or application must be ruled out. The selection of a suitable strain of a microorganism can be regarded as the primary requirement for the use as a probiotic. These cultures must be able to pass the stomach-duodenum barrier in a viable state and to multiply at the site of destination in the intestine. Additionally, they must be capable of producing antagonistic metabolites against a dominating saprophytic microflora resulting in a competitive growth. These abilities are common among lactic acid bacteria, e.g. lactobacilli and bifidobacteria. Yet, intended autochthonous species do not possess very good technological features for the enrichment in food specimens, because their viability will decrease rapidly under unfavourable conditions as it is the case with mineral supplements in feed or with low acidity in fermented dairy products. Therefore, some other microorganisms like spore-forming species or yeast cultures were introduced as probiotic components. These possess some similar features which render them suitable for probiotic use. But their physiological and ecological traits do not qualify them as probiotics of first choice. The special efficacy of probiotics must be strictly verified in animal nutrition due to restrictive EC-regulations, in pharmacy due to legal restraints, and in food applications in accordance with food law regulations. Safety aspects are considered very restrictively in feed applications, in the food and pharmaceutical sector they should be in accordance with the intended purpose of "fulfilling health claims". In the presented review the different requirements for the application of probiotics in animal nutrition, in food, and in pharmaceuticals will be provided. The special effect of competitive exclusion of pathogenetic and toxinogenic microorganisms in fowl performance are mentioned and even the application of probiotics as marine aquacultures of fish and Crustaceae will be included. Furthermore, the safety aspects resulting from the tremendous amount of industrially produced cultures which are distributed into the environment will be discussed. In conclusion it may be pointed out that probiotics may serve to partially replace the presently reduced or even prohibited application of nutritive antibiotics or chemotherapeutics in animal nutrition and in fulfillment of health claims in man and animals. Economic and environmental aspects will reduce the overall application of probiotics world-wide. Restrictions of use and controls of efficacy and safety are essential and must be implemented periodically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766268

Source DB:  PubMed          Journal:  Berl Munch Tierarztl Wochenschr        ISSN: 0005-9366            Impact factor:   0.328


  8 in total

1.  Screening for bacillus isolates in the broiler gastrointestinal tract.

Authors:  Teresa M Barbosa; Cláudia R Serra; Roberto M La Ragione; Martin J Woodward; Adriano O Henriques
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

2.  Probiotic Bacteria in Wound Healing; An In-Vivo Study.

Authors:  Astha Sinha; Shakti Sagar; Madhumathy M; W Jabez Osborne
Journal:  Iran J Biotechnol       Date:  2019-12-01       Impact factor: 1.671

3.  Complete genome sequence and antimicrobial activity of Bacillus velezensis JT3-1, a microbial germicide isolated from yak feces.

Authors:  Youquan Li; Xuan Li; Dan Jia; Junlong Liu; Jinming Wang; Aihong Liu; Zhijie Liu; Guiquan Guan; Guangyuan Liu; Jianxun Luo; Hong Yin
Journal:  3 Biotech       Date:  2020-05-05       Impact factor: 2.406

4.  Biocontrol of the food-borne pathogens Listeria monocytogenes and Salmonella enterica serovar Poona on fresh-cut apples with naturally occurring bacterial and yeast antagonists.

Authors:  Britta Leverentz; William S Conway; Wojciech Janisiewicz; Maribel Abadias; Cletus P Kurtzman; Mary J Camp
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

5.  Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.

Authors:  Satya Prakash; Mitchell Lawrence Jones
Journal:  J Biomed Biotechnol       Date:  2005

6.  Dietary Administration of Bacillus subtilis Enhances Growth Performance, Immune Response and Disease Resistance in Cherry Valley Ducks.

Authors:  Mengjiao Guo; Guangen Hao; Baohua Wang; Ning Li; Rong Li; Liangmeng Wei; Tongjie Chai
Journal:  Front Microbiol       Date:  2016-12-08       Impact factor: 5.640

7.  Production and stability of a multi-strain Bacillus based probiotic product for commercial use in poultry.

Authors:  Uraisha Ramlucken; Santosh O Ramchuran; Ghaneshree Moonsamy; Christine Jansen van Rensburg; Mapitsi S Thantsha; Rajesh Lalloo
Journal:  Biotechnol Rep (Amst)       Date:  2020-12-31

8.  Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572.

Authors:  Patricia Diez-Echave; Izaskun Martín-Cabrejas; José Garrido-Mesa; Susana Langa; Teresa Vezza; José M Landete; Laura Hidalgo-García; Francesca Algieri; Melinda J Mayer; Arjan Narbad; Ana García-Lafuente; Margarita Medina; Alba Rodríguez-Nogales; María Elena Rodríguez-Cabezas; Julio Gálvez; Juan L Arqués
Journal:  Nutrients       Date:  2021-05-29       Impact factor: 6.706

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.